Erin Colgan
2022
In 2022, Erin Colgan earned a total compensation of $855.3K as Chief Financial Officer at Sensei Biotherapeutics, a 30% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $132,020 |
|---|---|
| Option Awards | $206,188 |
| Salary | $410,000 |
| Stock Awards | $90,300 |
| Other | $16,808 |
| Total | $855,316 |
Colgan received $410K in salary, accounting for 48% of the total pay in 2022.
Colgan also received $132K in non-equity incentive plan, $206.2K in option awards, $90.3K in stock awards and $16.8K in other compensation.
Rankings
In 2022, Erin Colgan's compensation ranked 3,359th out of 5,760 executives tracked by ExecPay. In other words, Colgan earned more than 41.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,359 out of 5,760 | 42nd |
Division Manufacturing | 1,899 out of 3,136 | 39th |
Major group Chemicals And Allied Products | 904 out of 1,422 | 36th |
Industry group Drugs | 846 out of 1,323 | 36th |
Industry Pharmaceutical Preparations | 616 out of 969 | 36th |
Source: SEC filing on June 15, 2023.
Colgan's colleagues
We found three more compensation records of executives who worked with Erin Colgan at Sensei Biotherapeutics in 2022.